Burt Wealth Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Burt Wealth Advisors’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,019	Closed	-$5K	–	413
2018 Q2	$5K	Hold	2,019	–	–	﹤0.01%	314
2018 Q1	$6K	Hold	2,019	–	–	﹤0.01%	310
2017 Q4	$8K	Sell	2,019 -5,500	-73%	-$23.9K	0.01%	289
2017 Q3	$34K	Hold	7,519	–	–	0.02%	203
2017 Q2	$25K	Hold	7,519	–	–	0.02%	243
2017 Q1	$69K	Hold	7,519	–	–	0.05%	139
2016 Q4	$58K	Hold	7,519	–	–	0.05%	158
2016 Q3	$85K	Hold	7,519	–	–	0.09%	116
2016 Q2	$92K	Hold	7,519	–	–	0.1%	105
2016 Q1	$76K	Hold	7,519	–	–	0.07%	132
2015 Q4	$169K	Hold	7,519	–	–	0.14%	74
2015 Q3	$124K	Hold	7,519	–	–	0.15%	75
2015 Q2	$169K	Hold	7,519	–	–	0.18%	66
2015 Q1	$194K	Hold	7,519	–	–	0.2%	54
2014 Q4	$164K	Buy	+7,519	New	+$154K	0.17%	63

Other funds holding OMED

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Burt Wealth Advisors's OMED Position: Q3 2018 in Review

Burt Wealth Advisors sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q3 2018, closing a stake of 2,019 shares — an estimated $5K sold.

Burt Wealth Advisors first reported a position in OMED in Q4 2014 and held it in 15 quarters. The position peaked at $194K in Q1 2015. 54 funds tracked by Wall St. Rank hold OMED as of Q3 2018.

Burt Wealth Advisors reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Burt Wealth Advisors sold 2,019 OncoMed Pharmaceuticals, Inc. shares in Q3 2018, an estimated $5K.
Burt Wealth Advisors first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2014 and held it in 15 quarters.
Burt Wealth Advisors's OncoMed Pharmaceuticals, Inc. position peaked at $194K in Q1 2015.
54 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q3 2018.

Based on Burt Wealth Advisors's 13F filing for Q3 2018, filed 30 Oct 2018.